Page last updated: 2024-09-04

cyc 202 and DDD MPGNII

cyc 202 has been researched along with DDD MPGNII in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellis, D; Chiara, M; Davit, A; De Rosa, G; Di Simone, D; Giachino, O; Menegatti, E; Roccatello, D; Sena, LM; Sferch, D1
Meijer, L; Pippin, JW; Qu, Q; Shankland, SJ1

Other Studies

2 other study(ies) available for cyc 202 and DDD MPGNII

ArticleYear
Mycophenolate mofetil and roscovitine decrease cyclin expression and increase p27(kip1) expression in anti Thy1 mesangial proliferative nephritis.
    Clinical and experimental immunology, 2005, Volume: 139, Issue:2

    Topics: Animals; Cell Cycle Proteins; Cyclin B; Cyclin D; Cyclin-Dependent Kinase Inhibitor p27; Cyclins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Immunohistochemistry; In Situ Hybridization; Male; Models, Animal; Mycophenolic Acid; Purines; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Roscovitine; Th1 Cells; Tumor Suppressor Proteins

2005
Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.
    The Journal of clinical investigation, 1997, Nov-15, Volume: 100, Issue:10

    Topics: Animals; CDC2-CDC28 Kinases; Cell Cycle; Cell Nucleus; Cells, Cultured; Collagen; Cyclin-Dependent Kinase 2; Cyclin-Dependent Kinases; Enzyme Inhibitors; Fibronectins; Glomerular Mesangium; Glomerulonephritis, Membranoproliferative; Kidney Function Tests; Laminin; Protein Kinases; Protein Serine-Threonine Kinases; Purines; Rats; Rats, Wistar; Roscovitine

1997